MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: Preliminary results

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 59-68

  Cizmarikova, Martina ^a   Podracka, Ludmila ^a   Klimcakova, Lucia ^a   Habalova, Viera ^a   Boor, Andrej ^a   Mojzis, Jan ^a   Mirossay, Ladislav ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Genes; MDR; P Glycoprotein; Polymerase chain reaction

Indexed keywords

GLUCOCORTICOID; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISONE; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; STEROID;

ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DNA EXTRACTION; DNA POLYMORPHISM; DRUG DOSE REDUCTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPING TECHNIQUE; HAPLOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; KIDNEY BIOPSY; KIDNEY HYPOPLASIA; MALE; NEPHROTIC SYNDROME; ONSET AGE; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROLIFERATIVE GLOMERULONEPHRITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STEROID THERAPY; TREATMENT RESPONSE; URINALYSIS; GENETIC POLYMORPHISM; GENETICS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; PHARMACOGENETICS; REMISSION; RETROSPECTIVE STUDY; SLOVAKIA;

ALLELES; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HAPLOTYPES; HUMANS; MALE; NEPHROTIC SYNDROME; P-GLYCOPROTEINS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SLOVAKIA; STEROIDS;

EID: 84920499880     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.891366     Document Type: Article

References (37)

1. Perazella M: A 58-year-old man with diabetes mellitus and nephrotic syndrome. Hosp Physician, 2002; 38: 39-42
2. Orlowska-Kowalik G, Malecka-Massalska T, Ksiazek A: Elevated serum CA-125 levels in a patient with nephrotic syndrome. Am J Case Rep, 2008; 9: 351-54
3. Bagga A, Mantan M: Nephrotic syndrome in children. Indian J Med Res, 2005; 122: 13-28
4. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM: Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol, 2001; 16: 1040-44
5. Teeninga N, Kist-van Holthe JE, van Rijswijk N et al: Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol, 2013; 24: 149-59
6. Mortazavi F, Khiavi YS: Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran. Ther Clin Risk Manag, 2011; 7: 167-71
7. Chen Y, Zhao Y, Wang C et al: Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistence associated with P-glycoprotein in human leukemia K562 cells. Med Sci Monit, 2012; 18(10): BR383-88
8. Dilger K, Schwab M, Fromm MF: Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm Bowel Dis, 2004; 10: 578-83
9. Padowski JM, Pollack GM: Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Methods Mol Biol, 2010; 596: 359-84
10. Richaud-Patin Y, Soto-Vega E, Jakez-Ocampo J, Llorente L: P-glycoprotein in autoimmune diseases. Autoimmun Rev, 2004; 3: 188-92
11. Gollapud S, Gupta S: Anti P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival. J Clin Immunol, 2001; 21: 420-30
12. Hoffmeyer S, Burk O, von Richter O et al: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 2000; 97: 3473-78
13. Kimchi-Sarfaty C, Oh JM, Kim IW et al: A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science, 2007; 315: 525-28
14. Tang K, Ngoi SM, Gwee PC et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics, 2002; 12: 437-50
15. Kim RB, Leake BF, Choo EF et al: Identification of functionally variant MDR-1 allele among European Americans and African Americans. Clin Pharmacol Ther, 2001; 70: 189-99
16. Sakurai A, Onishi I, Hirano H et al: Quantitative structure-activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporte ABCB1 (P-glycoprotein/MDR1). Biochemistry, 2007; 43: 7678-93
17. Anglicheau D, Verstuyft C, Laurent-Puig P et al: Association of the multidrug resistance-1 gene single nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol, 2003; 14: 1889-96
18. Salama NN, Yang Z, Bui T, Ho RJ: MDR-1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant [LC-PK] cells. J Pharm Sci, 2006; 95: 2293-308
19. Wasilewska A, Zalewski G, Chyczewski L, Zoch-Zwierz W: MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol, 2007; 22: 44-51
20. Choi HJ, Cho HY, Ro H et al: Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatr Nephrol, 2011; 26: 1981-88
21. Jafar T, Prasad N, Agarwal V et al: MDR-1 gene polymorphisms in steroidresponsive versus steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant, 2011; 26(12): 3968-74
22. Youssef DM, Attia TA, El-Shal AS, Abduelometty FA: Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: Impact on susceptibility and response to steroids. Gene, 2013; 530: 201-7
23. Cascorbi I, Gerloff T, Johne A et al: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther, 2001; 69: 169-74
24. Pechandova K, Buzkova H, Slanar O, Perlik F: Polymorphisms of the MDR1 gene in the Czech population. Folia Biol, 2006; 52: 184-89
25. Sole X, Guino E, Valls J et al: SNPStats: a web tool for the analysis of association studies. Bioinformatics, 2006; 22: 1928-29
26. Ginsburg GS, Willard HF: Genomic and personalized medicine: foundations and applications. Transl Res, 2009; 154: 277-87
27. Wasilewska AM, Zoch-Zwierz WM, Pietruczuk M: Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids. Eur J Pediatr, 2006; 165: 839-44
28. Markova S, Nakamura T, Sakaeda T et al: Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. Drug Metab Pharmacokinet, 2006; 21: 194-200
29. Pawlik A, Baskiewicz-Masiuk M, Machalinski B et al: Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol, 2005; 528: 27-36
30. Stachowski J, Zanker CB, Runowski D et al: Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity. Pol Merkuriusz Lek, 2000; 8: 218-21
31. Huebner C, Browning BL, Petermann I et al: Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflamm Bowel Dis, 2009; 15: 1784-93
32. Sakaeda T: MDR1 genotype-related pharmacokinetics: fact or fiction? Drug Metabol Pharmacokinet, 2005; 20: 391-414
33. Marchetti S, Mazzanti R, Beijnen JH, Schellens JHM: Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, p-glycoprotein). Oncologist, 2007; 12: 927-41
34. Joshi S, Andersen R, Jespersen B, Rittig S: Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing. Acta Paediatr, 2013; 102: 844-56
35. Mubarak M, Kazi JI, Shakeel S et al: The spectrum of histopathological lesions in children presenting with steroid-resistant nephrotic syndrome at a single center in Pakistan. ScientificWorldJournal, 2012; 2012: 681802
36. Kari JA, Halawani M, Mokhtar G et al: Pattern of steroid resistant nephrotic syndrome in children living in the kingdomof Saudi Arabia: a single center study. Saudi J Kidney Dis Transpl, 2009; 20: 854-57
37. Seif EI, Ibrahim EAS, Elhefnawy NG, Salman MI: Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study. J Nephropathology, 2013; 2: 53-56